West Nile virus
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics begins installing screening systems at five U.S. and Canadian sites to prepare for screening trials by July 1, the company says April 22. Roche's WNV entry is the TaqScreen WNV real-time PCR instrument (1"The Gray Sheet" March 17, 2003, p. 8)...
You may also be interested in...
West Nile Virus Assay Makers Race To Meet FDA’s Testing Needs By Summer
Focus Technologies expects to be the first company to offer a West Nile Virus clinical diagnostic in the U.S
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.